SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH LISTED COMPANY


Any AUS or NZ company

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

LIFESPOT HEALTH LTD(LSH)

Click here for free access to this company's:
ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)

Former (or subsequent) names

 

Shareholder links

Our website ranking of LSH: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare, Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000LSH7
Address: Suite 103, Level 1, 2 Queen Street, Melbourne VIC 3000
Tel:  +61 (0) 3 8395 5446 Fax: +61 (0) 3 8678 1747

Date first listed: 11/01/2017
Company Secretary: Nova Taylor
Sector: Health Care Equipment & Services Industry Group: 
Activities: Development of telemedicine mobile applications

News & Events

Expand this box to read and print

The suspension of trading in the securities of Lifespot Health will be lifted from the commencement of trading on Friday, 2 October 2020, following the release by LSH of an announcement regarding a capital raising.

02/10/2020

The company releases an Appendix 2A.

02/10/2020

The company has issued 24,000,000 ordinary shares A$0.04 (4 cents) per share to Cannvalate Pty Ltd raising $960,000. Funds raised will be used to fund clinical trials on the Company's Medihale inhaler device and other novel cannabinoid inhalational devices, completion of the final stages of a BodyTel Fevertel workplace SaaS solution and ongoing marketing of the Fevertel home and workplace products. The company intends to allocate $770,000 towards the inhaler device clinical trials and $190,000 towards the BodyTel Fevertel product development and marketing costs.

02/10/2020

The securities of Lifespot Health Ltd will be suspended from quotation immediately under Listing Rule 17.2, at the request of LSH, pending the release of an announcement regarding a capital raising.

28/09/2020

listed entity carried for record purposes only

11/01/2017
OFX Transferring Money Internationally to Free

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    28/11/2019Rodney Hannington132,267$0.039$5,087
    31/10/2019Rodney Hannington100,000$0.050$5,000
    09/10/2018Rodney Hannington77,739$0.087$6,724

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Rodney HanningtonNon Exec Chairman, Independent Director12/04/2018
    Matthew GoldenCEO12/10/2020
    Frank CannavoNon Exec Director11/01/2017
    Justyn StedwellDirector19/05/2020

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Andreas EmplNon Exec Director13/01/202019/05/2020
    Greg PlunkettIndependent Director11/09/201813/01/2020
    Heinrich EmdenExecutive Director11/01/201701/02/2019
    Justyn StedwellDirector29/03/201812/04/2018
    David MandelNon Exec Chairman01/11/201729/03/2018
    Philippa LewisChairman01/09/201701/11/2017
    Mark TalbotNon Exec Director11/01/201701/11/2017
    Tilo BrandisNon Exec Chairman11/01/201731/08/2017
    Philip BekhorNon Exec Director11/01/201731/08/2017

    Date of first appointment, title may have changed.